SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹34,400 Cr | ₹26,449 Cr | ₹19,956 Cr | ₹17,656 Cr | ₹14,296 Cr |
What is the latest Net Current Assets ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹34,400 Cr |
| Mar2024 | ₹26,449 Cr |
| Mar2023 | ₹19,956 Cr |
| Mar2022 | ₹17,656 Cr |
| Mar2021 | ₹14,296 Cr |
How is Net Current Assets of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹34,400 Cr | 30.06 | |
| Mar2024 | ₹26,449 Cr | 32.54 | |
| Mar2023 | ₹19,956 Cr | 13.02 | |
| Mar2022 | ₹17,656 Cr | 23.50 | |
| Mar2021 | ₹14,296 Cr | - | |
Compare Net Current Assets of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,325.7 Cr | 4.7% | -0.3% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,800.0 Cr | 2.3% | 6.8% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,578.0 Cr | 2.5% | -1.7% | 26.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,075.0 Cr | 11.3% | 7.6% | 12.5% | Stock Analytics | |
| CIPLA | ₹105,662.0 Cr | 5.9% | 7.3% | -14.1% | Stock Analytics | |
| MANKIND PHARMA | ₹93,710.0 Cr | 1.6% | 14.2% | -11% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 4.7% |
-0.3% |
-3.1% |
| SENSEX | -3% |
5.8% |
-3.4% |
You may also like the below Video Courses